You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Regeneration of tissue to replace damaged or injured tissue is the goal of t- sue engineering. Biomaterials like polyglycolic acid, collagen and small-intestinal submuscosa provide a temporary scaffold to guide new tissue growth and or- nization. Typically, they need to be biodegradable, showing good cell atta- ment and proliferation and they should possess appropriate mechanical properties (Kim et al. , 2000). Synthetic polymers ful ll most of these requirements but lack cell-adhesion peptides on their surface to enhance cell attachment. Ce- adhesion peptides are present in ECM proteins like collagen and elastin. Thus a synthetic polymer coated with ECM proteins would result in a scaffold t...
With contributions from biotechnologists and bioengineers, this ready reference describes the state of the art in industrial biopharmaceutical production, with a strong focus on continuous processes. Recent advances in single-use technology as well as application guidelines for all types of biopharmaceutical products, from vaccines to antibodies, and from bacterial to insect to mammalian cells are covered. The efficiency, robustness, and quality control of continuous production processes for biopharmaceuticals are reviewed and compared to traditional batch processes for a range of different production systems.
This is the most comprehensive treatise of this topic available, providing invaluable information on the technological and economic benefits to be gained from implementing continuous processes in the biopharmaceutical industry. Top experts from industry and academia cover the latest technical developments in the field, describing the use of single-use technologies alongside perfusion production platforms and downstream operations. Special emphasis is given to process control and monitoring, including such topics as 'quality by design' and automation. The book is supplemented by case studies that highlight the enormous potential of continuous manufacturing for biopharmaceutical production facilities.
The ultimate guide for thought leader marketing! Grow your business and profoundly engage your customers in a digital era with fresh insights from Dr. Nagendra in The Thought Leader Way. – Marshall Goldsmith - Thinkers 50 #1 Executive Coach and only two-time #1 Leadership Thinker in the world. Thought leadership is a much-abused term in business. It often conceals thinly veiled self-promotion that is shallow and superficial. But Karthik Nagendra, as this book shows, takes a thoughtful and insightful view, emphasizing that thought leadership involves factors such as transparency and integrity that are vital to establishing trust and credibility. The book offers several examples to show how institutions can enhance their influence by sharing intellectual capital with those who wish to learn. That makes this book an important resource for all who wish to educate themselves about what thought leadership is, and what it is not. – Mukul Pandya Senior fellow, AI for Business, Wharton Customer Analytics/ Former Executive Director- Knowledge@Wharton The Wharton School, University of Pennsylvania
The past 30 years have seen the emergence of a growing desire worldwide that positive actions be taken to restore and protect the environment from the degrading effects of all forms of pollution – air, water, soil, and noise. Since pollution is a direct or indirect consequence of waste production, the seemingly idealistic demand for “zero discharge” can be construed as an unrealistic demand for zero waste. However, as long as waste continues to exist, we can only attempt to abate the subsequent pollution by converting it to a less noxious form. Three major questions usually arise when a particular type of pollution has been identi ed: (1) How serious is the pollution? (2) Is the techno...
The 18th ESACT meeting was celebrated in Granada (Spain) in May 2003, and was entitled "Animal Cell Technology Meets Genomics", in order to reflect that the emerging technologies in the area of genomics, proteomics and other "-omics"-type disciplines will provide key technological assets to increase knowledge and open new horizons in animal cell technology. During the meeting a variety of top-class emerging technologies were presented together with the lastest advances in more mature industrial areas. The meeting was opened by a first session devoted to the understanding of basic cellular mechanisms, and four sessions focused on applied aspects of animal cell technology: Cell-based therapies and gene-based therapies, target discovery and biopharmaceuticals. The Granada Meeting has also seen a special focus on forefront industrial case studies. The spirit and scientific excellence of the 18th ESACT meeting is now reflected in different chapters of the book. The book presents, in form of short papers, a high number of the contributions to the meeting, and has been prepared with the aim to provide a relevant reference of the current research efforts in Animal Cell Technology.
State-of-the-art research by leading experts ## Advanced feedstock production and processing ## Enzyme and microbial biocatalysis ## Bioprocess research and development ## Commercialization of biobased products.
The 21st ESACT conference was held in the beautiful surroundings of the CityWest Hotel resort in Dublin, Ireland. For the first time in ESACT history the number of participants exceeded 900: a sign of the ever increasing importance of this area. The conference commenced on Sunday June 5th with two sets of parallel workshops on the subjects listed below. An additional workshop was held on Monday lunchtime of the conferenceProcess Analytical Technology (PAT), Quality by Design (QbD) and other recent regulatory developments. 2. Innovative media products for the 21st century biopharmaceutical industry. 3. The impact of high titre media feed-streams on monoclonal antibody purification. 4. Advances in genomics and proteomics. 5. Stem Cell Technology: new developments and clinical applications.
The increased attendance required concurrent sessions for the 48 oral presentations and 190 submitted posters (for more details see Website: www.ct.ornl.gov/symposium). Attendees came from Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, Germany, Hungary, India, Japan, Korea, Mexico, The Netherlands, Russia, South Korea, Spain, Sweden, Turkey, and Ven ezuela, as well as from the United States. This international perspective was continued in a Special Topic Ses sion sponsored by the International Energy Agency (lEA) Bioenergy Pro gram on Biofuels and chaired by Jack Saddler and David Gregg from the University of British Columbia. Several of the 10 member countries in this...
153 posters. While plant biotechnology for enzyme production and designer biomass merged as "hot topics" throughout the Symposium, the preface for each session is included in the introductions. Special topic discussions were led on "Brazilian Bioethanol Progress" by Gisella Zanin, State University of Maringa, Brazil, and on "Nontradi tional Bioprocessing" by Gene Petersen, National Renewable Energy Labo ratory, Golden, CO. A tour of the Colorado Bioprocessing Center, a "state of the art" con tract research facility at Colorado State University highlighted the process development and scale-up activities ongoing with several industrial clients. The 1999 Charles D. Scott Award for Distinguished Contributions in the field of Biotechnology for Fuels and Chemicals was presented to Dr. Charles E. Wyman, Dartmouth College professor, Thayer School of Engineering, Hanover, New Hampshire. This award is named in honor of Dr. Charles D. Scott, the founder of this Symposium and its chair for the first ten years.